Search Results - "Longson, Carole"

Cancer Drugs Fund: the bigger picture by Longson, Carole M, Landells, Linda J, George, Elisabeth, Boysen, Meindert, Dillon, Andrew

“…[...]of whether the evidence is from clinical trials, observational data, or a combination of the two, NICE's appraisal is driven by its robustness and quality…”
Get full text

A little learning: reflections on 10 years of NICE technology appraisals by Longson, Carole M.

“…It is now almost 12 years since I joined National Institute for Health and Clinical Excellence (NICE). In those early years, neither I nor anyone else…”
Get full text

10 years of NICE: still growing and still controversial by Littlejohns, Peter, FRCP, Garner, Sarah, PhD, Doyle, Nick, BA, Macbeth, Fergus, FRCP, Barnett, David, FRCP, Longson, Carole, PhD

“…Summary The National Institute for Health and Clinical Excellence (NICE) will have existed for 10 years on April 1, 2009. Over the past decade, the institute's…”
Get full text

How can we get high quality routine data to monitor the safety of devices and procedures? by Campbell, Bruce, Stainthorpe, Andrew C, Longson, Carole M

“…Following recent problems with some medical devices, Bruce Campbell, Andrew Stainthorpe, and Carole Longson suggest some pragmatic steps to improve safety data…”
Get full text

HTAi Policy Forum: keeping HTA on track by Longson, Carole

Get more information

Foreward by the Director of the Centre for Health Technology Evaluation by Longson, Carole

Get full text

Antimicrobial resistance: a light at the end of the tunnel? by Leonard, Colm T, Ward, Derek, Longson, Carole

“…Additionally, the 11 agents with novel mechanisms of action are not all active against high-risk systemic, urinary tract, or respiratory infections; four of 11…”
Get full text

A Little Learning: Reflections On 10 Years Of Nice Technology Appraisals by Longson, Carole M

“…It is now almost 12 years since I joined National Institute for Health and Clinical Excellence (NICE). In those early years, neither I nor anyone else…”
Get full text

Localization of CAM II Kinase-α, GAD, GluR2 and GABAA Receptor Subunit mRNAs in the Human Entorhinal Cortex by Longson, Damien, Longson, Carole M., Jones, Edward G.

“…The human entorhinal cortex (ERC) is an important relay between neocortical association areas and the hippocampus. Pathology in this area, including…”
Get full text

How can we get high quality routine data to monitor the safety of devices and procedures? by Campbell, Bruce, Stainthorpe, Andrew, Longson, Carole

“…Difficulties with medical devices and discussions at the European Commission about new regulations have focused attention on how to introduce devices and…”
Get full text

The National Institute for Health and Clinical Excellence and Its Role in Assessing the Value of New Cancer Treatments in England and Wales by TROWMAN, Rebecca, CHUNG, Helen, LONGSON, Carole, LITTLEJOHNS, Peter, CLARK, Peter

“…The boundaries of medical science in the treatment of cancer are constantly extending. Developments of existing treatments, innovative approaches, new…”
Get full text

Journal of the Royal Society of Medicine. Foreward by the Director of the Centre for Health Technology Evaluation by Longson, Carole

Get full text

At the Center of Health Care Policy Making: The Use of Health Technology Assessment at NICE by Stevens, Andrew J., Longson, Carole

“…The UK’s National Institute for Health and Clinical Excellence (NICE), a world leader in health technology assessment (HTA), sits at the interface of a policy…”
Get full text

NICE Methodology for Technology Appraisals: Cutting Edge or Tried and Trusted? by Longworth, Louise, Longson, Carole

“…DOI: 10.2165/0019053-200826090-00003…”
Get full text

NICE methodology for technology appraisals: cutting edge or tried and trusted? by Longworth, Louise, Longson, Carole

Get full text

Erlotinib for the treatment of non-small-cell lung cancer by Kandaswamy, Prashanth, Boysen, Meindert, Longson, Carole, Stevens, Andrew

Get full text

Cardiac resynchronisation therapy for the treatment of heart failure: NICE technology appraisal guidance by Barnett, David, Phillips, Seren, Longson, Carole

“…This NICE technology appraisal guidance on cardiac resynchronisation therapy provides additional treatment options for some of the groups of people covered in…”
Get full text

Special Report: Policy: Erlotinib for the treatment of non-small-cell lung cancer by Kandaswamy, Prashanth, Boysen, Meindert, Longson, Carole, Stevens, Andrew

Get full text

Appraisal of bevacizumab and cetuximab for treatment of metastatic colorectal cancer in the UK by Barnett, David, Stevens, Andrew, Longson, Carole

Get more information

Rituximab for follicular non-Hodgkin lymphoma by Gajraj, Elangovan, Chung, Helen, Longson, Carole, Stevens, Andrew

Get full text